Table VIII.
Quality assessment of articles using Cochrane criteria
| Cochrane criteria | Chun et al., 2016 | Chowers et al., 2015 | Bessesen et al., 2013 | Hassan et al., 2007 | Montecalvo et al., 2001 | van Rijen et al., 2009 |
Wassenberg et al., 2011 |
|---|---|---|---|---|---|---|---|
| 1. Is the study population clearly described? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 2. Are competing alternatives clearly described? | No | Yes | Yes | No | No | No | Yes |
| 3. Is a well-defined research question posed in answerable form? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 4. Is the economic study design appropriate to the stated objective? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 5. Is the chosen time horizon appropriate to include relevant costs and consequences? | Moderate | Yes | No | No | No | Yes | Yes |
| 6. Is the actual perspective chosen appropriate? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 7. Are all important and relevant costs for each alternative identified? | Yes | Yes | Yes | Moderate | Yes | Yes | Yes |
| 8. Are all costs measured appropriately in physical units? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 9. Are costs valued appropriately? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 10. Are all important and relevant outcomes for each alternative identified? | Moderate | Moderate | Yes | Moderate | Moderate | Moderate | Yes |
| 11. Are all outcomes measured appropriately? | Yes | No | Yes | Moderate | Yes | Yes | Yes |
| 12. Are outcomes valued appropriately? | Yes | No | Yes | Yes | Yes | Yes | No |
| 13. Is an incremental analysis of costs and outcomes of alternatives performed? | Yes | Yes | Moderate | Moderate | Moderate | Moderate | No |
| 14. Are all future costs and outcomes discounted appropriately? | No | No | No | No | No | No | No |
| 15. Are all important variables, whose values are uncertain, appropriately subjected to sensitivity analysis? | Yes | Yes | No | No | No | No | No |
| 16. Do the conclusions follow from the data reported? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 17. Does the study discuss the generalizability of the results to other settings and patient/client groups? | No | Yes | Moderate | Yes | Moderate | Yes | Moderate |
| 18. Does the article indicate that there is no potential conflict of interest of study researcher(s) and funder(s)? | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 19. Are ethical and distributional issues discussed appropriately? | Yes | Yes | No | No | No | No | No |
| Overall assessment | |||||||
| High | 14 (73.7%) | 15 (78.9%) | 13 (68.4%) | 10 (52.6%) | 11 (57.9%) | 13 (68.4%) | 13 (68.4%) |
| Moderate | 2 (10.5%) | 1 (5.3%) | 2 (10.5%) | 4 (21.1%) | 3 (15.8%) | 2 (10.5%) | 1 (5.3%) |
| Low | 3 (15.8%) | 3 (15.8%) | 4 (21.1%) | 5 (26.3%) | 5 (26.3%) | 4 (21.1%) | 5 (26.3%) |